July 3 - The U.S. Food and Drug Administration has declined to approve Amneal Pharmaceuticals'
Amneal has been looking to rake in more than $500 million in revenues from its specialty business by 2027.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wearable movement-tracking data identify Parkinson’s disease years before clinical diagnosis - Nature MedicineUK Biobank motion tracking data show increased performance as compared to symptoms and genetic and lifestyle factors in identifying prodromal Parkinson's disease in the general population CynthiaSandor4 UKDRI
Source: NatureMedicine - 🏆 451. / 53 Read more »
$2.9 million gene therapy for severe hemophilia is approved by FDAU.S. health regulators have approved a gene therapy for the most common form of hemophilia.
Source: ABC - 🏆 471. / 51 Read more »
The Best Red Light Therapy Devices (and Why They Work)This FDA-approved treatment helps improve skin health and vitality while decreasing the appearance of acne, scars and signs of aging. RSRecommends
Source: RollingStone - 🏆 483. / 51 Read more »